New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareIGF-1 DES vs Semax

IGF-1 DES vs Semax

Side-by-side comparison of key properties, dosing, and research.

Anabolic & IGF
IGF-1 DES
Cognitive Enhancement
Semax
Summary
IGF-1 DES (also written DES(1-3)IGF-1) is a truncated form of IGF-1 missing the first three amino acids of the N-terminus. This structural change dramatically reduces its affinity for IGF binding proteins (IGFBPs), meaning a far greater fraction remains in its free, active form. IGF-1 DES is estimated to be 10x more potent than standard IGF-1 LR3 at the receptor level locally, making it particularly effective for site-specific muscle growth when injected intramuscularly.
Semax is a synthetic heptapeptide derived from ACTH developed in Russia. It is a potent nootropic that enhances memory, focus, and provides neuroprotection. Approved in Russia for cognitive disorders, stroke recovery, and traumatic brain injury.
Half-Life
~20–30 minutes (very short — designed for local action)
Minutes (but effects persist for hours via BDNF induction)
Admin Route
IM, SubQ
Intranasal, SubQ
Research
Typical Dose
20–50 mcg per injection site
0.25–1 mg (250–1000 mcg)
Frequency
Once daily, post-workout
1–2 times daily
Key Benefits
  • Estimated 10x greater potency at the receptor vs IGF-1 LR3 locally
  • Minimal IGFBP binding — nearly all active upon injection
  • Highly localized muscle growth effect when injected intramuscularly
  • Activates satellite cells for muscle fiber hyperplasia potential
  • Synergistic with GH peptides in post-workout anabolic protocols
  • Shorter half-life reduces systemic exposure vs IGF-1 LR3
  • Useful for site-specific muscle development
  • Enhances memory and learning
  • Improves focus and concentration
  • Increases mental energy and motivation
  • Provides neuroprotection via BDNF and NGF upregulation
  • Reduces cognitive decline
  • May alleviate ADHD symptoms
  • Supports recovery from brain injury and stroke
  • Fast-acting — effects within 30–60 minutes
  • Approved in Russia for cognitive disorders and stroke recovery
Side Effects
  • Hypoglycemia (most significant risk — especially post-workout)
  • Localized muscle swelling at injection site
  • Potential for jaw/organ growth (acromegalic effects) with prolonged high-dose use
  • Carpal tunnel syndrome with high doses
  • +1 more
  • Headache (rare, often from higher doses)
  • Anxiety or overstimulation at high doses
  • Sleep disruption if dosed too late
  • Irritability (uncommon)
Stacks With